Suicide is often impulsive Seelos (SEEL.Q) are looking to create a faster way for suicidal people to get help. Current treatments like SSRI’s and anti-depressants help some, but…
Taylor Gavinchuk
‘Cybin is the only green stock in my portfolio’ – r/shroomstocks Cybin (CYBN.NE) started out June 1st at $1.71 CAD and has since launched up to $2.72, a 60%…
The Jordan Peterson nerve You may have first heard of the Vagus nerve from the infamous breathing coach turned self-help junkie Wim Hof. Hof has become an iconic figure…
Natty Filament Health is fresh off a $10 million CAD raise backed by Cannacord that closed yesterday, priced at $0.50 per share. Tomorrow they will make the shift to…
Big ass IPO? Not really… ‘Shares soar as Atai Life Sciences IPO’s on the Nasdaq’ is the story being spun around Atai’s (ATAI.Q) first crack at going public last…
Steady as she goes It’s been a rough couple of quarters for the psychedelics sector at large. Some companies have been able to avoid the correction, but for the…
Rollbacks Yesterday Core One Labs (COOL.C) announced an 8:1 share rollback to prepare itself for a Nasdaq listing. Today the company has 114,600,611 common shares outstanding, after the rollback,…
+326% wtf? PharmaTher (PHRM.C), the Vancouver-based psychedelics company is on an impressive run. In the last month, the stock has rocketed from $0.19 CAD up to $0.81 CAD, a…
In the cannabis sector, there is a wide net of different types of companies from growers to extractors to logistics & tech and everything in-between. In the earlier days…
Atai is already a whale Although private, no shroom stock discussion is complete without mentioning Berlin-based Atai Life Sciences. The company has remained private since its inception in…